Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Moore

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Psycho-Oncology|April 28, 2007
The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancerGary Rodin, Andrew Walsh, Camilla Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 daysKarl Bélanger, Malcolm Moore, Sharyn D Baker, et al.
Stem Cells (Dayton, Ohio)|December 8, 2009
Cyclin C regulates human hematopoietic stem/progenitor cell quiescenceYasuhiko Miyata, Yan Liu, Vladimir Jankovic, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2003
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinaseGunhild Sommer, Valter Agosti, Imke Ehlers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital statusJanet Ellis, Judy Lin, Andrew Walsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agentsGregory R Pond, Lillian L Siu, Malcolm Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic AdenocarcinomaSpring Holter, Ayelet Borgida, Anna Dodd, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2021
Comparability and validity of cancer registry data in the northwest of RussiaAnton Barchuk, Rustam Tursun-Zade, Alexey Belayev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancerMargaret A Tempero, David Klimstra, Jordan Berlin, et al.
The Journal of Urology|April 1, 2015
Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell TumorsMadhur Nayan, Michael A S Jewett, Joan Sweet, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Psycho-Oncology|April 28, 2007
The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancerGary Rodin, Andrew Walsh, Camilla Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 daysKarl Bélanger, Malcolm Moore, Sharyn D Baker, et al.
Stem Cells (Dayton, Ohio)|December 8, 2009
Cyclin C regulates human hematopoietic stem/progenitor cell quiescenceYasuhiko Miyata, Yan Liu, Vladimir Jankovic, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2003
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinaseGunhild Sommer, Valter Agosti, Imke Ehlers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital statusJanet Ellis, Judy Lin, Andrew Walsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agentsGregory R Pond, Lillian L Siu, Malcolm Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic AdenocarcinomaSpring Holter, Ayelet Borgida, Anna Dodd, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2021
Comparability and validity of cancer registry data in the northwest of RussiaAnton Barchuk, Rustam Tursun-Zade, Alexey Belayev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancerMargaret A Tempero, David Klimstra, Jordan Berlin, et al.
The Journal of Urology|April 1, 2015
Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell TumorsMadhur Nayan, Michael A S Jewett, Joan Sweet, et al.
Pageof 13